top of page

1er Symposium canadien sur la COVID LONGUE

Tuesday, April 15, 2025, from 1pm – 2pm ET, Online via Zoom
Speakers:

image (7).png

Emilia Liana Falcone, MD, PhD, FRCPC

  • Director of the IRCM Post-COVID-19 Clinic (IPCO)

  • Director of the Microbiome and Mucosal Defenses Research Unit

  • Clinical Assistant Professor, Department of Medicine, Université de Montréal

  • Canada Research Chair in the Role of the Microbiome in Primary Immunodeficiencies (Tier 2)

DF Headshot.jpg

Douglas D. Fraser, MD, PhD, FRCPC

  • Professor and Clinician Scientist

  • Western University

Moderator:​

Susan Law, PhD

  • Knowledge Mobilization Lead, Long COVID Web

  • Associate Professor, Institute of Health Policy, Management and Evaluation

​

Session Overview:

This session will be focused on research updates from basic and clinical science. Dr. Douglas Fraser will present on the LC-Optimize Study, a multinational effort that identified long COVID sub-phenotypes by analyzing data from nearly 6,000 participants across four countries, and setting the stage for the LC-Revitalize trial to evaluate treatments for LC. Dr. Falcone will provide an update on the current status of Long COVID therapeutic trials and will explore host-microbe interactions at the intestinal barrier in Long COVID.

​

Attendees will have an opportunity to ask questions of the speakers following their presentations.​

bottom of page